Volume 68, Issue 2, Pages (August 2005)

Slides:



Advertisements
Similar presentations
Renal Stress Testing in the Assessment of Kidney Disease Lakhmir S. Chawla, Claudio Ronco Kidney International Reports Volume 1, Issue 1, Pages (May.
Advertisements

Electrical Muscle Stimulation Induces an Increase of VEGFR2 on Circulating Hematopoietic Stem Cells in Patients With Diabetes  Asa Hidmark, PhD, Ioannis.
Kamyar Kalantar-Zadeh  Kidney International 
Nina Vasavada, Rajiv Agarwal  Kidney International 
Figure 2 Percentage of CD19+/CD34+ cells with decreased CD81 median fluorescence intensity (MFI;
Alterations in blood leukocytes of G551D-bearing cystic fibrosis patients undergoing treatment with ivacaftor  Preston E. Bratcher, Steven M. Rowe, Ginger.
Reduced Frequency of Regulatory T Cells in Peripheral Blood Stem Cell Compared to Bone Marrow Transplantations  Céline Blache, Joe-Marc Chauvin, Aude.
Reduced endothelial progenitor cells in extracranial arterial stenosis but not intracranial arterial stenosis  Zhixin Huang, MD, PhD, Xiaohao Zhang, MD,
Anemia management in chronic kidney disease
Ellen Krautkrämer, Martin Zeier, Alexander Plyusnin 
Mitchell H. Rosner, W. Kline Bolton  Kidney International 
Immunologic defects in 22q11.2 deletion syndrome
Recruitment of myeloid and plasmacytoid dendritic cells in cervical mucosa during Chlamydia trachomatis infection  T. Agrawal, V. Vats, P.K. Wallace,
Altered Homeostasis of CD4+ Memory T Cells in Allogeneic Hematopoietic Stem Cell Transplant Recipients: Chronic Graft-versus-Host Disease Enhances T Cell.
Residual Cancer Lymphocytes in Patients With Chronic Lymphocytic Leukemia After Therapy Show Increased Expression of Surface Antigen CD52 Detected Using.
Volume 86, Issue 1, Pages (July 2014)
W.H. Abdulahad, Y.M. van der Geld, C.A. Stegeman, C.G.M. Kallenberg 
Activation and Expansion of CD8+ T Effector Cells in Patients with Chronic Graft- versus-Host Disease  Bryan M. Grogan, Laura Tabellini, Barry Storer,
Elevated Numbers of Immature/Transitional CD21− B Lymphocytes and Deficiency of Memory CD27+ B Cells Identify Patients with Active Chronic Graft-versus-Host.
FLT3 ligand administration after hematopoietic cell transplantation increases circulating dendritic cell precursors that can be activated by CpG oligodeoxynucleotides.
Direct Conversion of Skin Cells into Blood: Alchemy or Science?
Prehypertension and chronic kidney disease: the ox or the plow?
Reassessment of the care of the patient with chronic kidney disease
Volume 54, Issue 2, Pages (August 1998)
Kamyar Kalantar-Zadeh  Kidney International 
Jeffrey C. Fink, Glenn M. Chertow  Kidney International 
Volume 65, Issue 5, Pages (May 2004)
The progression of chronic kidney disease: A 10-year population-based study of the effects of gender and age  B.O. Eriksen, O.C. Ingebretsen  Kidney International 
Volume 59, Issue 3, Pages (March 2001)
Pathophysiologic features of “thin” endometrium
Volume 69, Issue 2, Pages (January 2006)
Chronic Kidney Dysfunction in Patients Alive without Relapse 2 Years after Allogeneic Hematopoietic Stem Cell Transplantation  Imad Abboud, Raphaël Porcher,
Volume 74, Issue 3, Pages (August 2008)
Volume 70, Issue 11, Pages (December 2006)
Volume 69, Issue 2, Pages (January 2006)
Bradley A. Ford, Daniel W. Coyne, Charles S. Eby, Mitchell G. Scott 
Volume 71, Issue 4, Pages (February 2007)
Impact of immunotherapy on blood dendritic cells in patients with Hymenoptera venom allergy  Katharina Dreschler, Kai Bratke, PhD, Sebastian Petermann,
Blood pressure targets in hemodialysis patients
Protective Immunity Transferred by Infusion of Cytomegalovirus-Specific CD8+ T Cells within Donor Grafts: Its Associations with Cytomegalovirus Reactivation.
Changes in the number of circulating TCM and TEM subsets in renal transplantation: relationship with acute rejection and induction therapy  David S. Segundo,
Volume 76, Issue 6, Pages (September 2009)
Expansion of cytolytic CD4+CD28− T cells in end-stage renal disease
Circulating CLA+ T cells from Acute and Chronic Psoriasis Patients Manifest a Different Activation State and Correlation with Disease Severity and Extension 
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Cardiovascular disease in pediatric chronic dialysis patients
Volume 75, Issue 5, Pages (March 2009)
The global challenge of chronic kidney disease
Circulating endothelial nitric oxide synthase inhibitory factor in some patients with chronic renal disease  Shen Xiao, Laszlo Wagner, Rebecca J. Schmidt,
(A) HLA-E expression on the surface of CD14+ cells in patients with AS, HLA-B*2705, HLA-B*2709-positive and HLA-B27-negative HCs. Results are expressed.
Nina Vasavada, Chandan Saha, Rajiv Agarwal  Kidney International 
Circulating Endothelial Progenitor Cells Are Increased in Patients with Classic Kaposi's Sarcoma  Adriano Taddeo, Pietro Presicce, Lucia Brambilla, Monica.
Residual Cancer Lymphocytes in Patients With Chronic Lymphocytic Leukemia After Therapy Show Increased Expression of Surface Antigen CD52 Detected Using.
Nina Vasavada, Rajiv Agarwal  Kidney International 
Volume 63, Issue 2, Pages (February 2003)
Volume 80, Issue 10, Pages (November 2011)
Is it the low-protein diet or simply the salt restriction?
Is complement a target for therapy in renal disease?
Volume 70, Issue 3, Pages (August 2006)
Toward a B-cell signature of tolerance?
Plasmacytoid Dendritic Cells: A New Cutaneous Dendritic Cell Subset with Distinct Role in Inflammatory Skin Diseases  Andreas Wollenberg, Sandra Günther,
Volume 70, Issue 10, Pages (November 2006)
Volume 75, Issue 5, Pages (March 2009)
CD11b-mediated migratory property of peripheral blood B cells
Volume 62, Issue 2, Pages (August 2002)
T Helper Type 2-Biased Natural Killer Cell Phenotype in Patients with Pemphigus Vulgaris  Hayato Takahashi, Masayuki Amagai, Akiko Tanikawa, Shigeaki.
Diagnostic testing and interpretation of tests for autoimmunity
Volume 55, Issue 5, Pages (May 1999)
Human BAT in allergic and normal control subjects.
Presentation transcript:

Volume 68, Issue 2, Pages 562-568 (August 2005) Increased levels of circulating endothelial cells in chronic periaortitis as a marker of active disease  Gabriella Moroni, Nicoletta Del Papa, Lorenza Mazzeo Moronetti, Claudio Vitali, Wanda Maglione, Denise P. Comina, Francesca Urgnani, Sandro Sandri, Claudio Ponticelli, Agostino Cortelezzi  Kidney International  Volume 68, Issue 2, Pages 562-568 (August 2005) DOI: 10.1111/j.1523-1755.2005.00434.x Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 1 Flow cytometry evaluation of circulating endothelial cells (CECs). (A) Representative panel showing the analysis gate used to exclude platelets and debris (left), and the gate used to exclude CD45-positive hematopoietic cells (right). (B) Representative panels showing the negative control, total, and microvascular CECs in chronic periaortitis. PerCP, peridin chlorophyll protein; PE, phycoerythrin; FITC, fluorescein isothiocyanate. Kidney International 2005 68, 562-568DOI: (10.1111/j.1523-1755.2005.00434.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 2 Levels of circulating endothelial cells (CECs) in peripheral blood obtained from patients with active chronic periaortitis (CP), healthy (HC), and atherosclerotic (ATS) controls. Data are shown as box plots, with upper and lower quartiles (shaded areas) and medians (horizontal lines within shaded areas). The number of CECs in CP patients was significantly higher when compared with those in controls. **P < 0.001. Kidney International 2005 68, 562-568DOI: (10.1111/j.1523-1755.2005.00434.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 3 Cell numbers during the course of immunosuppressive therapy in patients with active disease. Kidney International 2005 68, 562-568DOI: (10.1111/j.1523-1755.2005.00434.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 4 The activated phenotype of CECs was defined by P1H12 and CD62 surface expression. Data are shown as box plots, with upper and lower quartiles (shaded areas) and medians (horizontal lines within shaded areas). The number of activated CECs was markedly increased in patients with CP in comparison with atherosclerotic (ATS) and healthy (HC) controls. *P = 0.005. Kidney International 2005 68, 562-568DOI: (10.1111/j.1523-1755.2005.00434.x) Copyright © 2005 International Society of Nephrology Terms and Conditions